<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://www.fda.gov/oc/datacouncil/stylesheets/spl/spl.xsl" type="text/xsl"?><document xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 http://www.fda.gov/oc/datacouncil/schemas/spl/spl.xsd">
<id root="AC04939E-7641-48E6-31B3-1E6C897B5F60" />
<code code="34391-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Human prescription drug label" />
<title mediaType="text/x-hl7-title+xml">1.5% GLYCINE IRRIGATION, USP</title>
<effectiveTime value="20060510" />
<setId root="AC04939E-7641-48E6-31B3-1E6C897B5F60" />
<versionNumber value="1" />
<author>
<time />
<assignedEntity>
<id root="1203031A-11E2-4664-948F-3C70EE0C7F83" />
<representedOrganization>
<name>Hospira</name>
<addr />
</representedOrganization>
</assignedEntity>
</author>
<component>
<structuredBody>
<component>
<section>
<id root="BD2E39AE-99C7-B621-7DF9-B4516336DF0D" />
<effectiveTime value="20060510" />
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="0409-7974" codeSystem="2.16.840.1.113883.6.69" />
<name>Glycine</name>
<formCode code="C42947" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="IRRIGANT" />
<activeIngredient>
<quantity>
<numerator unit="g" value="1.5">
<translation code="C48155" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="GRAM" value="1.5" />
</numerator>
<denominator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Glycine</name>
<activeMoiety>
<activeMoiety>
<code code="TE7660XO1C" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Glycine</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Glycine</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>Water</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="mL" value="3000">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="3000" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code />
<formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG" />
<asContent>
<quantity>
<numerator value="4">
<translation code="C48474" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG" value="4" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="0409-7974-08" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43184" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CASE" />
</containerPackagedMedicine>
</asContent>
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<consumedIn>
<substanceAdministration>
<routeCode code="C38271" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="URETHRAL" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
</section>
</component>
<component>
<section>
<id root="D8A87F8B-E1CB-B454-48C0-3E73127831BC" />
<code code="42229-5" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="SPL UNCLASSIFIED SECTION" />
<title mediaType="text/x-hl7-title+xml" />
<text><paragraph><content styleCode="bold italics">NONELECTROLYTE IRRIGATING
FLUID FOR TRANSURETHRAL SURGICAL PROCEDURES.</content></paragraph><paragraph><content styleCode="bold">For Urologic Irrigation Only; Not For Injection By Usual
Parenteral Routes</content></paragraph><paragraph><content styleCode="bold">Flexible
Irrigation Container</content></paragraph><paragraph>Rx only</paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
<component>
<section>
<id root="A2D7204F-6C6E-8544-E03E-E4FF9C0A6B78" />
<code code="34089-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="DESCRIPTION SECTION" />
<title mediaType="text/x-hl7-title+xml">DESCRIPTION</title>
<text><paragraph>1.5% Glycine Irrigation, USP is a sterile, nonpyrogenic,
hypotonic, aqueous solution of glycine intended only for urologic irrigation
during transurethral surgical procedures.</paragraph><paragraph>Each 100 mL
contains 1.5 g of glycine in water for injection. The solution is nonelectrolytic,
hypotonic and has an osmolarity of 200 mOsmol/liter (calc.); pH 6.0 (4.5 to
6.5).</paragraph><paragraph>The solution contains no bacteriostat, antimicrobial
agent or added buffer and is intended only for use as a single-dose irrigation.
When smaller volumes are required, the unused portion should be discarded.</paragraph><paragraph>1.5%
Glycine Irrigation is a urologic nonelectrolyte irrigant.</paragraph><paragraph>Glycine,
USP is chemically designated aminoacetic acid (C<sub>2</sub>H<sub>5</sub>NO<sub>2</sub>),
a white crystalline powder freely soluble in water. It has the following structural
formula:</paragraph><paragraph>NH<sub>2</sub>CH<sub>2</sub>COOH</paragraph><paragraph>Water
for Injection, USP is chemically designated H<sub>2</sub>0.</paragraph><paragraph>The
flexible plastic container is fabricated from a specially formulated polyvinylchloride.
Water can permeate from inside the container into the overwrap but not in
amounts sufficient to affect the solution significantly.</paragraph><paragraph>The
semi-rigid container is fabricated from a specially formulated polyolefin.
It is a copolymer of ethylene and propylene. The container requires no vapor
barrier to maintain the proper drug concentration.</paragraph><paragraph>The
flexible plastic container is fabricated from a specially formulated polyvinylchloride.
Water can permeate from inside the container into the overwrap but not in
amounts sufficient to affect the solution significantly. Solutions in contact
with the plastic container may leach out certain chemical components from
the plastic in very small amounts; however, biological testing was supportive
of the safety of the plastic container materials. Exposure to temperatures
above 25&#176;C/77&#176;F during transport and storage will lead to minor
losses in moisture content. Higher temperatures lead to greater losses. It
is unlikely that these minor losses will lead to clinically significant changes
within the expiration period. </paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
<component>
<section>
<id root="3080E73B-4CAA-D6B7-BF6F-A92925A57F85" />
<code code="34090-1" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="CLINICAL PHARMACOLOGY SECTION" />
<title mediaType="text/x-hl7-title+xml">CLINICAL PHARMACOLOGY</title>
<text><paragraph>Glycine is an amino acid and a nonelectrolyte. A solution
of glycine in water is therefore nonconductive and suitable for urologic irrigation
during electrosurgical procedures. A 1.5%&#160;concentration of glycine in
water (200 mOsmol/liter calc.) is sufficient to minimize the risk of intravascular
hemolysis which can occur from absorption of plain water through open prostatic
veins during transurethral resection (TUR). It is hypotonic in relation to
the extracellular fluid (280&#160;mOsmol/liter). Any solution absorbed intravascularly
during transurethral prostatic or bladder surgery, although variable in amount
depending primarily on the extent of surgery, will be excreted by the kidney.
Studies have shown that the absorption of glycine does not cause significant
hemolysis (increase of free hemoglobin) or release significant amounts of
free ammonia in the blood. Glycine is rapidly degraded in the liver by glycine
oxidase.</paragraph><paragraph>Water is an essential constituent of all body
tissues and accounts for approximately 70% of total body weight. Average normal
adult daily requirement ranges from two to three liters (1.0 to 1.5&#160;liters
each for insensible water loss by perspiration and urine production).</paragraph><paragraph>Water
balance is maintained by various regulatory mechanisms. Water distribution
depends primarily on the concentration of electrolytes in the body compartments
and sodium (Na<sup>+</sup>) plays a major role in maintaining physiologic
equilibrium.</paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
<component>
<section>
<id root="5E5F68A1-6A5B-ED04-555B-2FE712CF9792" />
<code code="34067-9" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="INDICATIONS &amp; USAGE SECTION" />
<title mediaType="text/x-hl7-title+xml">INDICATIONS AND USAGE</title>
<text><paragraph>1.5% Glycine Irrigation, USP is indicated for use as irrigating
fluid during transurethral prostatic resection and other transurethral surgical
procedures.</paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
<component>
<section>
<id root="2EA5B73B-1523-D5B7-0B29-6FCC445D19AA" />
<code code="34070-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="CONTRAINDICATIONS SECTION" />
<title mediaType="text/x-hl7-title+xml">CONTRAINDICATIONS</title>
<text><paragraph>NOT FOR INJECTION BY USUAL PARENTERAL ROUTES.</paragraph><paragraph>Do
not use in patients with anuria.</paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
<component>
<section>
<id root="759ABBF9-1698-CD00-74A6-6B81A0E75B6E" />
<code code="34071-1" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="WARNINGS SECTION" />
<title mediaType="text/x-hl7-title+xml">WARNINGS</title>
<text><paragraph>FOR UROLOGIC IRRIGATION ONLY.</paragraph><paragraph>Solutions
for urologic irrigation must be used with caution in patients with severe
cardiopulmonary or renal dysfunction. Irrigating fluids used during transurethral
prostatectomy have been demonstrated to enter the systemic circulation in
relatively large volumes. Thus, glycine irrigating solution must be regarded
as a systemic drug. Absorption of large amounts of fluids containing glycine
may significantly alter cardiopulmonary and renal dynamics.</paragraph><paragraph>Do
not heat container over 66&#176;C (150&#176;F).</paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
<component>
<section>
<id root="5C9F9027-8E1F-E07B-3C5E-16084179554B" />
<code code="42232-9" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="PRECAUTIONS SECTION" />
<title mediaType="text/x-hl7-title+xml">PRECAUTIONS</title>
<text><paragraph>Cardiovascular status, especially of the patient with cardiac
disease, should be carefully observed before and during transurethral resection
of the prostate when using glycine irrigating solution, because the quantity
of fluid absorbed into the systemic circulation by opened prostatic veins
may produce significant expansion of the extracellular fluid and lead to fulminating
congestive heart failure. Shift of sodium free intracellular fluid into the
extracellular compartment following systemic absorption of solution may lower
serum sodium concentration and aggravate pre-existing hyponatremia.</paragraph><paragraph>Care
should be exercised if impaired liver function is known or suspected. Under
such conditions, ammonia resulting from metabolism of glycine may accumulate
in the blood.</paragraph><paragraph>Aseptic technique is essential with the
use of sterile solutions for irrigation. The administration set should be
attached promptly. Unused portions should be discarded and a fresh container
of appropriate size used for the start-up of each cycle or repeat procedure.</paragraph><paragraph>Do
not administer unless solution is clear, seal is intact and container is undamaged.
Discard unused portion.</paragraph></text>
<effectiveTime value="20060510" />
<component>
<section>
<id root="DD3E84DC-7E61-6ED9-12B6-8ABEB81A0406" />
<code code="34083-6" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION" />
<title mediaType="text/x-hl7-title+xml">Carcinogenesis, Mutagenesis, Impairment of Fertility:</title>
<text><paragraph>Studies with Glycine Irrigation, USP have not been performed
to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.</paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
<component>
<section>
<id root="B476A0E2-5027-F4D0-CC8C-87ECD6749111" />
<code code="34080-2" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="NURSING MOTHERS SECTION" />
<title mediaType="text/x-hl7-title+xml">Nursing Mothers:</title>
<text><paragraph>Caution should be exercised when Glycine Irrigation, USP
is administered to a nursing woman.</paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
<component>
<section>
<id root="259CB480-9F25-521A-1A1D-8CC543B998B4" />
<code code="42228-7" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="PREGNANCY SECTION" />
<title mediaType="text/x-hl7-title+xml">Pregnancy:</title>
<text><paragraph><content styleCode="italics">Teratogenic Effects.</content></paragraph><paragraph><content styleCode="italics">Pregnancy Category C.</content> Animal reproduction studies
have not been conducted with Glycine Irrigation, USP. It is also not known
whether Glycine Irrigation, USP can cause fetal harm when administered to
a pregnant woman or can affect reproduction capacity. Glycine Irrigation,
USP should be given to a pregnant woman only if clearly needed.</paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
<component>
<section>
<id root="9575A6BB-6792-2BB0-9CDB-B9E3D0F1AD18" />
<code code="34081-0" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="PEDIATRIC USE SECTION" />
<title mediaType="text/x-hl7-title+xml">Pediatric Use:</title>
<text><paragraph>The safety and effectiveness of Glycine Irrigation have not
been established. Its limited use in pediatric patients has been inadequate
to fully define proper dosage and limitations for use.</paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
</section>
</component>
<component>
<section>
<id root="47999912-E519-2C7C-F3F2-A1AF33254826" />
<code code="34084-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="ADVERSE REACTIONS SECTION" />
<title mediaType="text/x-hl7-title+xml">ADVERSE REACTIONS</title>
<text><paragraph>Adverse reactions may result from intravascular absorption
of glycine. Large intravenous doses of glycine are known to cause salivation,
nausea and lightheadedness. Other consequences of absorption of urologic irrigating
solutions include fluid and electrolyte disturbances such as acidosis, electrolyte
loss, marked diuresis, urinary retention, edema, dryness of mouth, thirst,
dehydration, coma from hyponatremia, secondary hyponatremia due to fluid overload,
and hyper- ammonemia with resultant coma and/or encephalopathy; cardiovascular
disorders such as hypotension, tachycardia, angina-like pains; pulmonary disorders
such as pulmonary congestion; and other general reactions such as blurred
vision, convulsions, nausea, vomiting, rhinitis, chills, vertigo, backache,
transient blindness and urticaria. Allergic reactions from glycine are unknown
or exceedingly rare.</paragraph><paragraph>Should any adverse reaction occur,
discontinue the irrigant, evaluate the patient, institute appropriate therapeutic
countermeasures and save the remainder of the fluid for examination if deemed
necessary.</paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
<component>
<section>
<id root="5C6D7688-6156-D3F6-94A8-5C87CD2A2218" />
<code code="34088-5" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="OVERDOSAGE SECTION" />
<title mediaType="text/x-hl7-title+xml">OVERDOSAGE</title>
<text><paragraph>In the event of overhydration or solute overload, re-evaluate
the patient and institute appropriate corrective measures. See WARNINGS, PRECAUTIONS
and ADVERSE REACTIONS.</paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
<component>
<section>
<id root="6AEA8C29-F1F4-12C9-1483-D35B3CAF0AE9" />
<code code="34068-7" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="DOSAGE &amp; ADMINISTRATION SECTION" />
<title mediaType="text/x-hl7-title+xml">DOSAGE AND ADMINISTRATION</title>
<text><paragraph>1.5% Glycine Irrigation, USP should be administered only
by transurethral instillation with appropriate urologic instrumentation. A
disposable irrigation set should be used. The total volume of solution used
for irrigation is solely at the discretion of the surgeon.</paragraph><paragraph>Height
of container(s) above the operating table in excess of 60 cm (approx. 2 ft.)
has been reported to increase intravascular absorption of the irrigating fluid.</paragraph><paragraph><content styleCode="bold">Drug Interactions</content></paragraph><paragraph>Additives
may be incompatible. Consult with pharmacist, if available. When introducing
additives, use aseptic technique, mix thoroughly and do not store.</paragraph><paragraph>Parenteral
drug products should be inspected visually for particulate matter and discoloration
prior to administration, whenever solution container permits. See PRECAUTIONS.</paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
<component>
<section>
<id root="0A9F4333-65ED-4244-8C42-76DC786CB1E4" />
<code code="34069-5" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="HOW SUPPLIED SECTION" />
<title mediaType="text/x-hl7-title+xml">HOW SUPPLIED</title>
<text><paragraph>1.5% Glycine Irrigation, USP is supplied in single-dose 3000
mL flexible irrigation container  (&#160;List No.&#160;7974).</paragraph><paragraph>Exposure
of pharmaceutical products to heat should be minimized. Avoid excessive heat.
Protect from freezing. Store at 20 to 25&#176;C (68 to 77&#176;F). [See USP
Controlled Room Temperature.]</paragraph><table frame="void"><caption />
<colgroup>
<col />
<col />
<col />
</colgroup>
<tbody>
<tr><td valign="top" /><td valign="top" /><td align="right" valign="top" /></tr>
<tr><td valign="top"><paragraph>&#169;Hospira 2004</paragraph></td><td align="center" valign="top"><paragraph>EN-0577</paragraph></td><td align="right" valign="top"><paragraph>Printed in USA</paragraph></td></tr>
</tbody>
</table><paragraph><content styleCode="italics">HOSPIRA, INC., LAKE FOREST,
IL 60045 USA</content></paragraph></text>
<effectiveTime value="20060510" />
</section>
</component>
</structuredBody>
</component>
</document>
